17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of PLA2G5 mRNA CTD PMID:15212814 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PLA2G5 mRNA CTD PMID:17351261 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLA2G5 mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:735328 6480464 Dihydrotestosterone results in increased expression of PLA2G5 mRNA CTD PMID:29581250 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62343 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G5 mRNA CTD PMID:33956508 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G5 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735328 6480464 [Decitabine co-treated with IFNG protein] results in increased expression of PLA2G5 mRNA CTD PMID:18953428 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PLA2G5 mRNA CTD PMID:25825206 6-propyl-2-thiouracil decreases expression ISO RGD:62343 6480464 Propylthiouracil results in decreased expression of PLA2G5 mRNA CTD PMID:36706583 aflatoxin B1 increases methylation ISO RGD:735328 6480464 Aflatoxin B1 results in increased methylation of PLA2G5 intron CTD PMID:30157460 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G5 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of PLA2G5 protein CTD PMID:16483693 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLA2G5 mRNA CTD PMID:16483693 arachidonic acid multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Arachidonic Acid] CTD PMID:9495842 arsane affects expression ISO RGD:735328 6480464 Arsenic affects the expression of PLA2G5 mRNA CTD PMID:18414638 arsenic atom affects expression ISO RGD:735328 6480464 Arsenic affects the expression of PLA2G5 mRNA CTD PMID:18414638 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of PLA2G5 mRNA CTD PMID:36841081 benazepril decreases expression EXP 6480464 benazepril results in decreased expression of PLA2G5 mRNA CTD PMID:14871019 benzalkonium chloride decreases expression ISO RGD:62343 6480464 Benzalkonium Compounds results in decreased expression of PLA2G5 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO RGD:62343 6480464 Benzo(a)pyrene results in increased expression of PLA2G5 mRNA CTD PMID:27195522 benzo[a]pyrene increases methylation ISO RGD:735328 6480464 Benzo(a)pyrene results in increased methylation of PLA2G5 3' UTR more ... CTD PMID:27901495 benzo[e]pyrene increases methylation ISO RGD:735328 6480464 benzo(e)pyrene results in increased methylation of PLA2G5 intron CTD PMID:30157460 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G5 mRNA] CTD PMID:17109745 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLA2G5 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:62343 6480464 bisphenol A results in increased expression of PLA2G5 mRNA CTD PMID:32156529 bisphenol A increases methylation ISO RGD:62343 6480464 bisphenol A results in increased methylation of PLA2G5 promoter CTD PMID:27312807 bisphenol A decreases methylation ISO RGD:62343 6480464 bisphenol A results in decreased methylation of PLA2G5 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLA2G5 mRNA CTD PMID:25181051 bisphenol F decreases expression EXP 6480464 4, 4'-bisphenol F results in decreased expression of PLA2G5 mRNA CTD PMID:26186136 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PLA2G5 mRNA CTD PMID:25808797 CGP 52608 multiple interactions ISO RGD:735328 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLA2G5 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:62343 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLA2G5 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:62343 6480464 Cisplatin results in increased expression of PLA2G5 mRNA CTD PMID:15471895 clofibrate multiple interactions ISO RGD:62343 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA] CTD PMID:17585979 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PLA2G5 mRNA CTD PMID:26577399 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PLA2G5 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:62343 6480464 Dibutyl Phthalate results in decreased expression of PLA2G5 mRNA CTD PMID:17361019 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:19915844 doxorubicin decreases expression ISO RGD:735328 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:62343 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of PLA2G5 mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:62343 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:21040762 enzalutamide decreases expression ISO RGD:735328 6480464 enzalutamide results in decreased expression of PLA2G5 mRNA CTD PMID:29581250 epoxiconazole increases expression ISO RGD:62343 6480464 epoxiconazole results in increased expression of PLA2G5 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:62343 6480464 Ethanol results in increased expression of PLA2G5 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:62343 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLA2G5 mRNA CTD PMID:20938992 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of PLA2G5 mRNA CTD PMID:17285311 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 glycidol increases expression EXP 6480464 glycidol results in increased expression of PLA2G5 mRNA CTD PMID:24395379 hydrogen peroxide increases expression ISO RGD:62343 6480464 Hydrogen Peroxide results in increased expression of PLA2G5 mRNA CTD PMID:14729362 hydrogen peroxide affects expression ISO RGD:735328 6480464 Hydrogen Peroxide affects the expression of PLA2G5 protein CTD PMID:21179406 icosanoid multiple interactions ISO RGD:62343 6480464 PLA2G5 protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids], PLA2G5 protein promotes the reaction [Peptidoglycan results in increased metabolism of Eicosanoids] CTD PMID:17369491 isoliquiritigenin decreases expression ISO RGD:735328 6480464 isoliquiritigenin results in decreased expression of PLA2G5 mRNA CTD PMID:23747687 L-methionine multiple interactions ISO RGD:62343 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLA2G5 mRNA CTD PMID:20938992 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of PLA2G5 mRNA CTD PMID:21864555 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of PLA2G5 mRNA CTD PMID:22641619 leukotriene C4 multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] CTD PMID:9495842 leukotriene C4 multiple interactions ISO RGD:62343 6480464 PLA2G5 protein promotes the reaction [Zymosan results in increased metabolism of Leukotriene C4] CTD PMID:14761945 lipopolysaccharide multiple interactions ISO RGD:735328 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLA2G5 mRNA CTD PMID:35811015 methamphetamine increases expression ISO RGD:735328 6480464 Methamphetamine results in increased expression of PLA2G5 mRNA CTD PMID:25290377 methapyrilene increases methylation ISO RGD:735328 6480464 Methapyrilene results in increased methylation of PLA2G5 intron CTD PMID:30157460 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases activity ISO RGD:735328 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased activity of PLA2G5 protein CTD PMID:11741884 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Arachidonic Acid], PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] CTD PMID:9495842 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases secretion ISO RGD:735328 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of PLA2G5 protein CTD PMID:11741884 N-nitrosodiethylamine multiple interactions ISO RGD:62343 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PLA2G5 gene CTD PMID:23968726 naphthalene increases expression ISO RGD:62343 6480464 naphthalene results in increased expression of PLA2G5 mRNA CTD PMID:18978301 paracetamol multiple interactions ISO RGD:62343 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentanal decreases expression ISO RGD:735328 6480464 pentanal results in decreased expression of PLA2G5 mRNA CTD PMID:26079696 peptidoglycan multiple interactions ISO RGD:62343 6480464 PLA2G5 protein promotes the reaction [Peptidoglycan results in increased metabolism of Eicosanoids] CTD PMID:17369491 piperonyl butoxide multiple interactions ISO RGD:62343 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PLA2G5 gene CTD PMID:23968726 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PLA2G5 mRNA CTD PMID:20726854 progesterone decreases expression ISO RGD:62343 6480464 Progesterone results in decreased expression of PLA2G5 mRNA CTD PMID:22238285 propanal decreases expression ISO RGD:735328 6480464 propionaldehyde results in decreased expression of PLA2G5 mRNA CTD PMID:26079696 prostaglandin E2 multiple interactions ISO RGD:62343 6480464 PLA2G5 protein promotes the reaction [Zymosan results in increased metabolism of Dinoprostone] CTD PMID:14761945 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PLA2G5 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735328 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLA2G5 mRNA CTD PMID:35811015 sarin decreases expression ISO RGD:735328 6480464 Sarin results in decreased expression of PLA2G5 mRNA CTD PMID:19522546 sarin increases expression ISO RGD:735328 6480464 Sarin results in increased expression of PLA2G5 mRNA CTD PMID:19522546 silicon dioxide increases expression ISO RGD:735328 6480464 Silicon Dioxide analog results in increased expression of PLA2G5 mRNA CTD PMID:25895662 tert-butyl hydroperoxide increases expression ISO RGD:62343 6480464 tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA CTD PMID:14729362 , PMID:15336504 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA CTD PMID:32741896 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 trimellitic anhydride affects expression ISO RGD:62343 6480464 trimellitic anhydride affects the expression of PLA2G5 mRNA CTD PMID:19042947